What is the point in trying to talk up the share price and...

What is the point in trying to talk up the share price and ignoring that Peter Cook is the biggest impediment to shareholders wealth? To ignore that the idiot continues to fail reporting important price-sensitive news such as the extension to patents and his more polished way of talking down the sp is to bury one’s head in the sand.

Yes, it is only a matter of time the sp will moved upwards as there are clear and convincing evidences of Relenza demand and the huge potentials of LANI.

Let me recap the drivers for BTA sp:

1) The production of 190million courses p.a is great news. This is equivalent to about $316 million royalties p.a.
With viral resistance to Tamiflu and psychotic problems for young Tamiflu users, Roche is increasing production capacity to 400 million courses. During the Avianflu outbreak, Relenza only managed about 5% of the antiviral market. Recent orders had Relenza ranging from 33% (Australian order) to 100% in some orders found by HC readers. Why is Peter Cook accepting GSK 190 million capacity and claiming credit for the increased in Relenza sales when Roche sold 1billion Swiss Francs of Tamiflu!

2) LANI phase 3 result is due any day now. LANI is a 1-dose antiviral. A successful launch in Japan by Daiichi Sankyo will have LANI becoming a flagship antiviral more successful than Relenza or Tamiflu.

3) The share brokers’ research report on BTA website will have to update their valuation to take into consideration the tripling of Relenza production to 190 m courses. This will boost the sp.

BTA shareholders:
- Even though the share price is trending upwards to reflect the Relenza royalties, we are still being short changed by GSK. Peter Cook should be getting on the phone to Andrew Witty and demand why Roche is increasing capacity to 400million compare to GSK’s 190 million.

-Why is Peter Cook making idiotic statements down talking Relenza potential?
Why is Peter Cook failing to announce extensions to Patents?

-Why is Peter Cook claiming credits (for GSK and himself) when Tamiflu is seriously outselling Relenza despite all the problems inflicting Tamiflu?
(Not withstanding the up trending sp) are you going to bury your head in the sand to praise Peter Cook?

- are you going to stand by idly to see Peter Cook diluting your shares with his options which he reward himself for impeding your wealth?

Come on shareholders, if Peter Cook resign tomorrow, the sp will shoot upwards in multiples!